Effect of wenxin granule on ventricular remodeling and myocardial apoptosis in rats with myocardial infarction

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wu, Aiming ^a   Zhai, Jianying ^b   Zhang, Dongmei ^a   Lou, Lixia ^a   Zhu, Haiyan ^a   Gao, Yonghong ^a   Chai, Limin ^a   Xing, Yanwei ^c   Lv, Xiying ^a   Zhu, Lingqun ^a   Zhao, Mingjing ^a   Wang, Shuoren ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b National Engineering Research Center for R and D of TCM Multi ingredient Drugs   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DNA NUCLEOTIDYLEXOTRANSFERASE; HERBACEOUS AGENT; METOPROLOL TARTRATE; UNCLASSIFIED DRUG; WATER; WENXIN GRANULE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CHINESE MEDICINE; CONTROLLED STUDY; DRUG GRANULE; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RAT; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE REMODELING; HEART WEIGHT; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TABLET; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84884236094     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/967986     Document Type: Article

References (37)

1. McManus D. D., Piacentine S. M., Lessard D., Gore J. M., Yarzebski J., Spencer F. A., Goldberg R. J., Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. The American Journal of Cardiology 2011 108 4 477 482 2-s2.0-79960904136 10.1016/j.amjcard.2011.03.074
2. Rumana N., Kita Y., Turin T. C., Murakami Y., Sugihara H., Morita Y., Tomioka N., Okayama A., Nakamura Y., Abbott R. D., Ueshima H., Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI registry, 1990-2001. The American Journal of Epidemiology 2008 167 11 1358 1364 2-s2.0-44449138146 10.1093/aje/kwn064
3. Yi S., Lei W., Minzhou Z., Progress in the epidemiological study of acute myocardial infarction. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 2012 10 4 467 469
4. Lacey L., Tabberer M., Economic burden of post-acute myocardial infarction heart failure in the United Kingdom. European Journal of Heart Failure 2005 7 4 677 683 2-s2.0-19544361992 10.1016/j.ejheart.2004.10.020
5. Baklanov D. V., Kaltenbach L. A., Marso S. P., Subherwal S. S., Feldman D. N., Garratt K. N., Curtis J. P., Messenger J. C., Rao S. V., The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the national cardiovascular data registry (2007 to 2011). Journal of the American College of Cardiology 61 4 420 426
6. Falsini G., Liistro F., Ducci K., Angioli P., Baldassarre S., Sabini A., Burali A., Bolognese L., Shifting from pharmacological to systematic mechanical reperfusion therapy for acute myocardial infarction via a cooperating network: impact on reperfusion rate and in-hospital mortality. Journal of Cardiovascular Medicine 2008 9 3 245 250 2-s2.0-40049098132 10.2459/JCM.0b013e328224b959
7. Gupta S., Das S., Sahewalla R., Gupta D., Gupta I., Prakash R., Bansal S., Rastogi R., A study on quality of life in patients following myocardial infarction. Indian Journal of Physiology and Pharmacology 2012 56 1 28 35
8. Wang W., Thompson D. R., Ski C. F., Liu M., Health-related quality of life and its associated factors in Chinese myocardial infarction patients. European Journal of Preventive Cardiology. In press
9. Mangiapane S., Busse R., Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis. Deutsches Arzteblatt 2011 108 50 856 862 2-s2.0-84856441245 10.3238/arztebl.2011.0856
10. Abbate A., Biondi-Zoccai G. G. L., Bussani R., Dobrina A., Camilot D., Feroce F., Rossiello R., Baldi F., Silvestri F., Biasucci L. M., Baldi A., Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. Journal of the American College of Cardiology 2003 41 5 753 760 2-s2.0-0037420098 10.1016/S0735-1097(02)02959-5
11. Kirkpatrick J. N., Sutton M. S. J., Assessment of ventricular remodeling in heart failure clinical trials. Current Heart Failure Reports 2012 9 4 328 336 10.1007/s11897-012-0116-6
12. Gajarsa J. J., Kloner R. A., Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Failure Reviews 2011 16 1 13 21 2-s2.0-78650985392 10.1007/s10741-010-9181-7
13. Kang P. M., Izumo S., Apoptosis and heart failure: a critical review of the literature. Circulation Research 2000 86 11 1107 1113 2-s2.0-0034625535
14. Hojo Y., Saito T., Kondo H., Role of apoptosis in left ventricular remodeling after acute myocardial infarction. Journal of Cardiology 2012 60 2 91 92 10.1016/j.jjcc.2012.05.014
15. Sam F., Sawyer D. B., Chang D. L., Eberli F. R., Ngoy S., Jain M., Amin J., Apstein C. S., Colucci W. S., Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. The American Journal of Physiology-Heart and Circulatory Physiology 2000 279 1 H422 H428 2-s2.0-0033862037
16. Abbate A., Biondi-Zoccai G. G. L., Baldi A., Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. Journal of Cellular Physiology 2002 193 2 145 153 2-s2.0-0036836660 10.1002/jcp.10174
17. Shah A. M., Hung C. L., Shin S. H., Skali H., Verma A., Ghali J. K., Køber L., Velazquez E. J., Rouleau J. L., McMurray J. J. V., Pfeffer M. A., Solomon S. D., Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. The American Heart Journal 2011 162 4 685 691 2-s2.0-80053633441 10.1016/j.ahj.2011.07.015
18. Spinelli L., Morisco C., di Panzillo E. A., Izzo R., Trimarco B., Reverse left ventricular remodeling after acute myocardial infarction: the prognostic impact of left ventricular global torsion. International Journal of Cardiovascular Imaging 2013 29 4 787 795 10.1007/s10554-012-0159-5
19. Jayasankar V., Woo Y. J., Pirolli T. J., Bish L. T., Berry M. F., Burdick J., Gardner T. J., Sweeney H. L., Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. Journal of Cardiac Surgery 2005 20 1 93 101 2-s2.0-12944265531 10.1111/j.0886-0440.2005.200373.x
20. Liu W., Jiang R., Ding S., Fu W., Wang S., Li X., Kang J., Wu D., Liu B., Mao W., He L., Liu B., Quality assessment of randomized controlled trials on Wenxin granule for treatment of atrial fibrillation. Zhongguo Zhong Yao Za Zhi 2012 37 1 109 114 2-s2.0-84859488035 10.4268/cjcmm20120123
21. Wang X., Gu Y., Wang T., Huang C., Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: involvement of Ltype calcium and transient outward potassium currents. Molecular Medicine Reports 2013 7 2 519 524
22. Wang M., Yu Y. B., Huang S. E., Clinical observation on effect and safety of combined use of wenxin granule and amiodarone for conversion of auricular fibrillation. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006 26 5 445 448 2-s2.0-38049095113
23. Xing Y., Gao Y., Chen J., Zhu H., Wu A., Yang Q., Teng F., Zhang D., Xing Y., Gao K., He Q., Zhang Z., Wang J., Shang H., Wenxin-Keli regulates the calcium/calmodulin-dependent protein kinase II signal transduction pathway and inhibits cardiac arrhythmia in rats with myocardial infarction. Evidence-Based Complementary and Alternative Medicine 2013 2013 15 464508 10.1155/2013/464508
24. Fishbein M. C., Maclean D., Maroko P. R., Experimental myocardial infarction in the rat. Qualitative and quantitative changes during pathologic evolution. The American Journal of Pathology 1978 90 1 57 70 2-s2.0-0017804803
25. Zhou Y. C., Liu B., Li Y. J., Jing L. L., Wen G., Tang J., Xu X., Lv Z. P., Sun X. G., Effects of Buyang Huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 385247 10.1155/2012/385247
26. Wang J., Xiong X., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 268542 10.1155/2012/268542
27. Park J. J., Beckman-Harned S., Cho G., Kim D., Kim H., The current acceptance, accessibility and recognition of Chinese and Ayurvedic medicine in the United States in the public, governmental, and industrial sectors. Chinese Journal of Integrative Medicine 2012 18 6 405 408 10.1007/s11655-012-1110-2
28. Qiu S. L., Jin M., Yi J. H., Zhu T. G., Quan X., Liang Y., Therapy for replenishing qi, nourishing yin and promoting blood circulation in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 2009 7 7 616 621 2-s2.0-73849126281 10.3736/jcim20090704
29. Li Y. Q., Jin M., Qiu S. L., Wang P. L., Zhu T. G., Wang C. L., Li T. C., Liu H. X., Bian H., Yao L. F., Shi D. Z., Effect of Chinese drugs for supplementing Qi, nourishing yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization. Chinese Journal of Integrative Medicine 2009 15 1 19 25 2-s2.0-60849112257 10.1007/s11655-009-0019-7
30. Su N., Xu T., Tang Y., Zhou Z., Efficacy and safety of Wenxin granules in the treatment of congestive heart failure: a systematic review. China Pharmacy 2010 21 7 637 640
31. Cimmino G., Ibanez B., Giannarelli C., Prat-González S., Hutter R., Garcia M., Sanz J., Fuster V., Badimon J. J., Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol. International Journal of Cardiology 2011 153 3 256 261 2-s2.0-81855190682 10.1016/j.ijcard.2010.08.018
32. Ricci R., Coletta C., Ceci V., Pajes G., Putini R. L., Salustri A., Bottero G., Pasquale M., Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling. The American Heart Journal 2001 142 4, article E5 2-s2.0-0035489952
33. Han S. Y., Li H. X., Ma X., Zhang K., Ma Z. Z., Jiang Y., Tu P. F., Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats. Journal of Ethnopharmacology 2013 145 3 722 727 10.1016/j.jep.2012.11.036
34. Dai W., Kloner R. A., Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction. Postgraduate Medicine 2011 123 2 49 55 2-s2.0-79955090250 10.3810/pgm.2011.03.2263
35. Kajstura J., Cigola E., Malhotra A., Li P., Cheng W., Meggs L. G., Anversa P., Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. Journal of Molecular and Cellular Cardiology 1997 29 3 859 870 2-s2.0-0031105576 10.1006/jmcc.1996.0333
36. Leri A., Claudio P. P., Li Q., Wang X., Reiss K., Wang S., Malhotra A., Kajstura J., Anversa P., Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. Journal of Clinical Investigation 1998 101 7 1326 1342 10.1172/JCI316
37. Tsai K. H., Lee N. H., Chen G. Y., Hu W. S., Tsai C. Y., Chang M. H., Jong G. P., Kuo C. H., Tzang B. S., Tsai F. J., Tsai C. H., Huang C. Y., Dung-shen (Codonopsis pilosula) attenuated the cardiac-impaired insulin-like growth factor II receptor pathway on myocardial cells. Food Chemistry 2013 138 2-3 1856 1867 10.1016/j.foodchem.2012.11.056